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Loading the chemotherapeutic agents in nanoemulsions system has recently gained attraction in medicine due to their 
ability to improve the drug’s efficacy and reduce its adverse effects. In this context, here, we loaded bleomycin (BLM) in 
nanoemulsion (NE) consisting of cinnamon oil in order to evaluate its antineoplastic effect on the SKOV-3 cells. The 
produced NE formulas were physically characterized by the zetasizer. The cytotoxic activities of BLM and NE formulas 
were examined by CCK-8 kit, Coomassie blue staining for the visualization of the morphological changes, Annexin V-FITC 
for identifying apoptosis and cell death detection ELISA plus kit for DNA fragmentation measurement. The average droplet 
diameter of the blank NE (450.90±1.57 nm) was increased when loaded with BLM (522.57±0.85 nm) while the magnitude 
of the negative zeta potential of the loaded formula (0.381±0.003 mV) was less than the blank NE (1.01±0.020 mV). The 
potential cytotoxicity of the BLM-NE was significantly greater than the toxicities of the free BLM and blank NE. The blank 
NE and BLM-NE have the greatest apoptotic effect and higher enrichment factor compared to free BLM. Loading BLM in 
NE based on cinnamon oil has considerably improved its efficacy as an anticancer drug on the SKOV-3 cells. 
Keywords: Anticancer drug, Antineoplastic effect, Apoptosis, Cinnamomum verum, Cytotoxicity, DNA fragmentation, 
Drug delivery, Essential oils  
Ovarian disease considered the fifth significant  
reason for cancer death and the main cause of 
gynecological malignancy death. In addition, it is 
considered as the second gynecological malignancy 
most commonly diagnosed
1
. Worldwide, over  
0.314 million people are suffering from ovarian 
cancer constituting 1.6% of all the cites/types with a 
fatality reported as 0.207 million
2
. Nevertheless, the 
underlying pathophysiology remains delineated
1
. 
Cancer chemotherapy is a standard therapy to treat 
tumors. Chemotherapeutic drugs can kill cancer cells 
and inhibit tumor growth. However, the major 
drawback of chemotherapy that systemic distribution 




Bleomycin (BLM) is an antibiotic antitumor 
commonly used in various types of cancer treatment
5
. 
BLM's therapeutic efficacy is limited because of its 
low diffusion into the cancer site as well as its short 
half-life
6
. BLM is unable to cross the plasma 
membrane to reach the site of action efficiently due to 
a relatively large molecular weight
5
. Moreover, a high 
level of BLM resulting in serious side effects of lung 
fibrosis
7
. Therefore, new formulations are needed to 
lower the side effects of BLM and improve their 
therapeutic efficacy. One of the most common 
applications of nanoparticles in oncology is to 
enhance the performance of chemotherapeutic drugs 
where bioavailability, safety, and specificity are 





Essential oils (EO's) based nanoemulsions have 
recently gained attention in medicine
9-12
. Firstly, EO's 
naturally exhibit excellent anticancer activities
13
. 
Secondly, nanoemulsions are capable of decreasing 
droplet size diameter to nanometric scale which 
increase the bioavailability and the solubility of drugs 
and thereby cause easier permeation of active 
compounds into blood vessels
14
. Saxena et al.
15
 have 
recently used functionalized gold nanoparticles with 
cell penetrating peptide for effective delivery of 
drugs, particularly in cancer treatment. EO's and their 
components play a significant role in cancer 
protection and therapy
13,16,17
. Furthermore, these EO's 
have shown synergistic effects when combined with 
chemotherapeutic agents
18
. Therefore, in the current 
study we tried to formulate BLM in NE-based 
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cinnamon oil and evaluated antitumor potential of 
BLM-loaded-NE against SKOV-3 cells in vitro. 
 
Materials and Methods 
 
Chemicals and subjects 
Polyoxyethylene-20-sorbitan monooleate (Tween 
80) and Sorbitan laurate (span 20) were purchased 
from Techno Pharamchem (India). Cinnamon oil was 
ordered from the secret of Egypt (Sharm El Sheikh, 
Egypt). Dulbecco’s modification of eagles medium 
(DMEM), 0.25% Trypsin- EDTA, Penicillin 
streptomycin and phosphate-buffered saline (1XPBS, 
pH7.4) were obtained from UFC biotech (Riyadh, 
KSA). Fetal bovine serum (FBS) was purchased from 
Biochrom (Berlin, Germany). Dimethyl sulfoxide 
(DMSO) was purchased from Thermo Fisher 
Scientific (USA). Dialysis bag was ordered from 
Spectrum Laboratories, Inc. (California, USA). 
Bleomycin (15 units) was purchased from Fresenius 
Kabi (India). Cell counting kit-8 (Lot. No LE612) was 
purchased from Dojindo molecular technologies 
(Japan). Annexin V-FITC apoptosis detection kit 
(Cat. No MBS668896) was purchased from 
MyBioSource (California, USA). Cell death detection 
Elisa plus (Cat. No 11774425001) was purchased 
from Roche (Mannheim, Germany). Phosphate buffer 
(pH7) and a buffer solution (pH8) were ordered from 
AppliChem GmbH (Germany). The human ovarian 
cancer cell line (SKOV-3) was obtained from the 
Tissue Culture Bank at King Fahad Medical Research 
Center, King Abdulaziz University (Jeddah, KSA). 
 
Preparation of the NE formulas  
The blank oil-in-water (o/w) NE formulation was 
prepared by mixing 13 % (v/v) of surfactant mixture 
of span 20 and tween 80 at a ratio of 1:2, respectively, 
7 % (v/v) of the oil phase (cinnamon oil) and 80 % of 
aqueous phase (buffer solution pH8). The mixture 
was emulsified directly by sonication using OMNI 
Sonic Ruptor 4000 (USA) at 50% power until it 
becomes clear. Then, the resulting blank NE was 
stored at room temperature (25ºC). The stock 
solution of 1.0 mg/mL of BLM was produced by 
dissolving BLM in sterile distilled water. For 
formulation of BLM-NE, the IC50 of BLM was 
directly mixed with the IC50 of the prepared blank NE. 
 
Physical characterization of BLM-NE formula 
The analysis of the droplet size of the produced NE 
was performed by Zetasizer (Malvern Instruments, 
Malvern, UK) as described elesewhere
19
. The charges 
and sizes of the NE were expressed as z-average 
diameters and zeta potentials, respectively. 
Measurements were performed three times at 25°C. 
 
In vitro drug release study 
The drug release study was used to evaluate the 
impact of the nanocarrier on the drug release profile
20
. 
Briefly, 1.0 mL of the examined formula was 
introduced into a dialysis bag, sealed at both ends, and 
suspended in a 250 mL beaker containing phosphate 
buffer (pH7). The whole system was kept at 37°C 
with continuous shaking at 100 rpm/min on a 
magnetic stirrer (Thermo fisher scientific, USA). 
About 1.0 mL of sample was collected at a regular 
time interval (0, 1, 2, 3, 4, 5, 6 and 24 h) and then, 
replaced by the same amount of phosphate buffer. The 
absorbance of the samples was measured at 300 nm 
using a UV-Visible spectrophotometer (Thermo 
Fisher Scientific, USA). 
 
Cell culture  
The SKOV-3 cell line was cultivated in a 25 cm
2
 
cell culture flask containing DMEM which was 
supplemented with 10% (v/v) FBS and 1% (v/v) 
penicillin-streptomycin in a 5% CO2 humidified 
incubator at 37°C
21
. The media was changed every  
48 h until cells reached confluence. Then, cells were 
washed with 1.0 mL of PBS, detached by adding  
1.0 mL of trypsin and finally incubated at 37°C. 
 
Dose-response effect  
The cell counting kit (CCK-8) was used to evaluate 
the cytotoxicity of drug and NE formulations against 
SKOV-3 cells
22
. 100 µL of culture media containing 
cells was seeded in each well of a 96-well plate and 
was incubated overnight at 37°C in a CO2 incubator. 
Then, cells were treated with  200 µL of five different 
concentrations for single formulas of each BLM, blank 
NE, and three loaded formulas at different ratios  
(1:1, 1:2, and 2:1) by mixing the IC50 of each BLM and 
blank NE. Then, cells were incubated for 24 h at 37
o
C in 
a CO2 incubator. About 5 μL of CCK-8 solution was 
then added to each well and incubated in a CO2 
incubator for 4 h. Finally, the absorbance was measured 
of each well by a microplate reader at 450 nm (Biotech, 
US). Wells, included culture media, were considered 
negative control while culture media containing cells 
served as a positive control. The experiments of each 
sample were performed in triplicate (n = 3). The 
percentages of cell growth inhibition rate were 
determined by the following equation:  
Growth inhibition (%) = 
100
control‎ positive of Abs
control) negative of Abs - cells  treatedof (Abs

 




Characterization of cell morphology using a light microscope  
Cultured cells were seeded at a density of 1×10
4
 
cells per well into a flat-bottomed 96-well tissue 
culture plates containing 100 µL of growth medium 
per well and incubated for 24 h at 37°C in a CO2 
incubator
23
. Cells were re-incubated with 200 µL of 
media containing drug and NE formulas for 24 h at 
37°C in a CO2 incubator. Then, they were washed 
with 100 µL of PBS for 5 min and fixed by the 
addition of 4% formaldehyde for 5 min. After that, the 
fixation solution was discarded and the cells were 
stained with 100 µL of 10% Coomassie blue dye for 
10 min. Finally, the dye was discarded and cells were 
washed five times with tap water and left to dry at 
room temperature. Morphological changes were 
observed by phase-contrast inverted microscope 
(Olympus 1X51, Japan). 
 
Detection of apoptosis  
Annexin V-FITC kit enables quantitative 
determination and fluorescent detection by flow 
cytometry of annexin V linked to apoptotic cells. 
Briefly, annexin V conjugated with fluorescein 
isothiocyanate (FITC) that stains the phosphatidylserine 
sites, which are located on the membrane surface of 
apoptotic cells
24
. In addition, it includes propidium 
iodide (PI) that stains the cellular DNA in necrotic 
cells. All cultured cells plated into 6-well flat-
bottomed tissue culture plates at a density of 2×10
5
 
cells per well containing 1.0 mL of the growth 
medium, and incubated for 24 h at 37°C in a CO2 
incubator. Cells were re-incubated with 2 mL of drug 
and NE formulations for 24 h at 37°C in a CO2 
incubator. Then, cells were washed with 1000 µL 
PBS, detached with 300 µL and incubated for 3 min 
followed by addition of 2000 µL of culture media. 
After that, cells were transferred to a tube and 
centrifuged for 10 min at 220×g. The supernatant was 
removed; pre-cooled PBS was added and cells were 
centrifuged at 400×g for 5 min (this step was repeated 
twice). Detached cells were re-suspended in 100 µL 
of the binding buffer after removing the supernatant. 
Thehe mixture was transferred to a flow cytometry 
tube followed by addition of 5 µL of annexin V and  
5 µL of PI (without control) and incubated at room 
temperature (25
o
C) for 15 min away from light. 
Finally, 400 µL of the binding buffer was added and 
the cell suspension was applied to BD FACSAriaTM 
III Flow Cytometer (BD Biosciences, US). FACS 
Diva software (version 6.1.3) was used to analyze the 
data. The positive FITC identifies the release of PS, 
which occurs in the early stage of apoptosis and the 
positive of PI identifies necrotic cells. 
 
DNA fragmentation detection 
Cell death detection ELISA plus kit was used to 
measure histone release from the nucleus and DNA 
fragmentation during the apoptosis
25,26
. About 100 µL 
of culture media containing cells was seeded in each 
well of a 96-well plate and incubated overnight at 
37°C in a CO2 incubator. At first, the 96-well plate 
was centrifuged for 10 min at 200×g and the 
supernatant was discarded. Next, 200 µL of lysis 
buffer was added to each well and incubated 30 min 
at room temperature. Then, the lysate was centrifuged 
at 200×g for 10 min. After that, 20 µL of the 
supernatant was transferred to a streptavidin-coated 
microplate and 80 µL of immunoreagent was added to 
each well. The microplate was covered with adhesive 
foil and incubated on shaker under gently shaking 
(300 rpm) at room temperature. After 2 h, the solution 
was removed thoroughly by tapping and each well 
was rinsed three times with 250 µL of incubation 
buffer. 100 µL ABTS was added to each well and 
incubated for 10 min on a plate shaker. Finally, it was 
measured using a microplate reader at 405 nm 
(BioTek, US). The enrichment factor was determined 
as absorbance of test samples/absorbance of control 
cells, which was used as an apoptosis parameter. 
 
Statistical analysis  
 ata were expressed as mean   standard deviation 
(     ). Statistical analyses were performed with a 
one-factor analysis of variance (ANOVA) and the 
independent sample t-test using MegaStat (version 
10.3, Butler University, Indianapolis, IN). The 
statistically significant differences were considered 




Physical measurements using zetasizer 
According to Table 1, the z-average diameter of the 
blank NE was significantly increased when loaded with 
BLM. Interestingly, the variation coefficients among 
the nanodroplet sizes for both blank NE and BLM-NE 
Table 1 — Zetasizer measurements of the produced NE formulas. 






Blank NE 450.90±1.57 0.003±0.0001 1.01±0.020 
BLM-NE 522.57±0.85 0.002±0.0003 0.381±0.003 
P value <0.001 >0.05 <0.001 
[P value was measured by the pairwise t-test between Blank NE 
and BLM-NE. BLM, bleomycin; and NE, nanoemulsion] 
 




were very small, indicating the homogeneous 
distribution of the droplet sizes. In terms of the zeta 
potential, the magnitude of the negative zeta potential 
of BLM-NE was less than blank NE.  
 
Drug release study  
Dialysis method was performed to determine the in 
vitro release of BLM and BLM-NE to examine the 
impact of nanoemulsion on the drug release. As 
illustrated in Fig. 1, loading BLM in NE was found  
to have a very highly significant release pattern 
compared to free drug. In other words, around 94% of 
BLM-NE was released within 24 h while only 37% of 
BLM was released in the same period of time.  
 
Determination of cell viability using CCK-8  
The % of cell viability and the half-maximal 
inhibitory concentration (IC50) of BLM and blank NE 
were evaluated for 24 h at different concentrations. As 
displayed in Fig. 2, there was a steady decline in the 
SKOV-3 viabilities as the concentration of the 
subjected formulas increase. In fact, the viabilities  
of cells displayed a sharp drop with increase 
concentrations when subjected to blank NE. On the 
other hand, the viabilities of cells were gradually 
decreased when subjected to BLM. It was clearly 
shown that the reduction of cells was significantly 
higher when subjected to blank NE than BLM. It has 
been found that the IC50 of the tested blank NE was 
less than the IC50 of BLM. In particular, the IC50’s of 
blank NE and BLM were estimated 0.40±0.001 µM 
and 3.5±0.003 µM, respectively.  
In terms of the combination formulas, loading BLM 
in NE at different ratios had more cytotoxicity than the 
single formulas (Table 2) and 2BLM:1NE, which 
consisted of 2.33 µM of BLM and 0.133 µM  of blank 
NE, was selected for further studies because it has the 
best toxic effect on the viabilities of SKOV-3 cells. 
 
Morphological examination of SKOV-3 cells 
As shown in Fig 3, cells exhibited morphological 
changes after treatment for 24 h at the IC50’s of the 
single and NE formulas. Cells demonstrated  
changes in morphology, membrane blebbing and 
chromatin condensation when treated with BLM. 
Cells treated with blank NE and loaded formulas  
have shown changes in shape, the formation of 
apoptotic bodies, chromatin fragmentation and 
membrane blebbing. It should be noted that the 
intercellular spaces were observed in all of the cells 
treated with the tested formulas and increased in the 
ratio of 2BLM:1NE. 
 
 
Fig. 1 —Release profile of BLM and BLM-NE using the dialysis 
method within 24 h at 37°C. [Error bars represent the standard 
deviation for n =3. (***) refers to very highly significant  




Fig. 2 —Percentage of cell viability of SKOV-3 cells treated for 
24 h at different concentrations of the tested formulas. Error bars 
represent the standard deviation for n =3. (* & **) refer to the 
significant (P < 0.05) and highly significant (P < 0.01) differences 
between BLM and Blank NE. 
 
Table 2 — Cytotoxicity effect of BLM incorporated into the NEs 
at different ratios of (3.5±0.003 µM) BLM in (0.40±0.001 µM) 






BLM 3.50 50.00±1.20 - 












37.38± 0.36*** <0.001***(very highly 
significant difference) 
[The percentages of cell viabilities are expressed as   ± SD.  
P value was measured by the pairwise t-test between BLM and the 
other tested formulae.  BLM, bleomycin; and NE, nanoemulsion] 
 




Annexin V-FITC apoptosis detection assay 
Double staining with FITC/PI can differentiate 
between necrotic (Q1), viable (Q3), early apoptotic 
(Q4) and late apoptotic (Q2) cells. As exhibited in 
Fig. 4, both of blank NE and BLM-NE had a 
markedly more apoptotic effect than BLM (P <0.001). 
In contrast, BLM had a more necrotic effect than  
the NE formulas. The percentages of viable cells 
subjected to the blank NE and BLM-NE were 
considerably less than those subjected to BLM.  
Cell death detection 
The extent of cellular DNA fragmentation was 
estimated by measuring the enrichment factor. 
According to Fig. 5, cells treated with the blank NE 
and BLM-NE had greater enrichment factors than 
those treated with BLM.  
 
Discussion 
In the present study, oil in water (O/W) NE 
formulations based on cinnamon oil were developed 
 
 
Fig. 3 — Light microscopy images of SKOV-3 cells treated with BLM and NEs formulas for 24h. [Coomassie blue was used for staining 
and images were magnified at 40×. Signs of apoptosis are represented by arrows as chromatin fragmentation (F), chromatin condensation 




Fig. 4 — Flow cytometry measurements of the percentages of the viable (Q3), necrotic (Q1) and apoptotic (Q2+Q4) SKOV-3 cells 
treated with the tested formulas for 24 h and double-stained with Annexin V FITC and PI. Error bars represent the standard deviation for 
n=3. (*, ** & ***) refer to the significant (P <0.05), highly significant (P <0.01) and very highly significant (P <0.001) differences 
between the tested formulas.  
 




to deliver BLM into SKOV-3 cells. It was reported 
that the administration of BLM in W/O emulsion 
showed poor potency as there was a slight 
accumulation of BLM. On the other hand, the 
administration of BLM in O/W emulsion led to a 
noticeable accumulation of the drug
27
. The clinical 
application of BLM has been limited due to its severe 
side effects and impermeability to the cell 
membrane
28
. Thus, O/W nanoemulsions might control 
the drawback of this drug by improving the 
bioavailability, drug stability, and lower adverse 
effects
29
. Moreover, O/W NEs are one of the most 
promising colloidal delivery system suitable for 
encapsulating Eos
30,31
 which they have the ability to 
decrease the volatilization and degradation of Eos
32
. 
As it appears in the results, the average droplet 
diameters of blank NE have increased when loaded 
with BLM implying that BLM was incorporated into 
the core of the nano-suspension droplets
9,12
. In 
addition, the NE formulations have a negative zeta 
potential which implies that the negatively charged 
nanocarriers accumulated more efficiently inside the 
cells and thereby could be potentially more toxic
33
. 
The release rate of BLN from NE was significantly 
higher than that of free BLM. Similar results showed 
that the release rate of the drug from the self-
nanoemulsifying drug delivery system was markedly 
higher compared with a drug suspension
34
. 
The cytotoxic activity of both NE and drug 
formulations was assessed in SKOV-3 cells for 24 h 
by CCK-8 assay. The results indicated that the cells 
showed an increase in their sensitivity when subjected 
to blank NE and BLM- loaded NE based on cinnamon 
oil when compared to cells treated with free BLM. 
Our findings are in agreement with several studies 
which previously confirmed that the cytotoxicity of 
BLM and various EO’s were enhanced when included 
in different nanocarriers system
35-40
. It has been 
reviewed that cinnamon oil and its active constituents 
exert antiproliferative activity and cytotoxic effect 
against various types of human cancer cells
41,42
. Our 
finding revealed that the IC50 of BLM decreased when 
loaded in NE. Previous study demonstrated that the 
IC50 of BLM loaded nanostructured lipid particle was 





Within 24 h, the best level of apoptosis was 
observed in blank NE and BLM-NE followed by free 
BLM. In agreement with our study, previous reports 
revealed that Bleomycin sulfate loaded nanostructured 
lipid particles induces a significantly greater degree of 
apoptosis in comparison to BLM
36
. Moreover, it has 
been found that using nanoliposomes as a carrier for 
BLM leads to an increase in apoptotic cells in 
comparison to conventional BLM
28
. 
According to DNA fragmentation analysis, there 
was an increase in DNA fragmentation of BLM when 
loaded in NE compared to free BLM. A similar study 
exhibited that there was an enhancement in DNA 
double-strand breaks in cells treated with gold 






The results reveal that Blank NE had the best 
cytotoxic effect among all the tested formulas and the 
efficacy of BLM was improved when formulated in 
NE. Our finding data evinced that BLM-NE based on 
cinnamon oil may have the capability to prolong the 
drug release rate, improved its cytotoxic and apoptotic 
effects on SKOV-3 cells. It is recommended to apply 
the new formulas in animal models in order to 
investigate the adverse side effects of the NE 
formulas on the organs and tissues.   
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Fig. 5 — Quantification of nucleosomal DNA fragmentation of 
cells treated with BLM, blank NE and 2BLM:1NE in SKOV-3 
cells after 24h incubation. Error bars represent the standard 
deviation for n=3. (*, ** & ***) refer to the significant (P< 0.05), 
highly significant (P <0.01) and very highly significant  
(P <0.001) differences between the tested formulas.  
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